VREOF - Vireo Health International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 577.93M
Enterprise Value 392.17M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.93
Price/Book (mrq)0.79
Enterprise Value/Revenue 33.47
Enterprise Value/EBITDA 6-10.91

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 318.22%
52 Week High 35.0626
52 Week Low 30.8798
50-Day Moving Average 31.2108
200-Day Moving Average 31.8693

Share Statistics

Avg Vol (3 month) 3107.62k
Avg Vol (10 day) 3125.35k
Shares Outstanding 523.68M
Float 23.52M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 219/1
Last Split Date 3Mar. 20, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Sep. 30, 2019

Profitability

Profit Margin -79.23%
Operating Margin (ttm)-41.12%

Management Effectiveness

Return on Assets (ttm)-6.59%
Return on Equity (ttm)-30.30%

Income Statement

Revenue (ttm)26.59M
Revenue Per Share (ttm)0.31
Quarterly Revenue Growth (yoy)62.30%
Gross Profit (ttm)16.78M
EBITDA -8.45M
Net Income Avi to Common (ttm)-21.07M
Diluted EPS (ttm)-0.2470
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.36M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)23.05M
Total Debt/Equity (mrq)22.92
Current Ratio (mrq)9.27
Book Value Per Share (mrq)1.18

Cash Flow Statement

Operating Cash Flow (ttm)-18.92M
Levered Free Cash Flow (ttm)-21.43M